SESAUA annual meeting featured a kidney cancer session and a presentation by Dr. Robert Smith discussing how age and tumor ...
Direct-to-consumer germline testing for cancer predisposition without oversight and guidance can cause anxiety, financial distress or other harms. People who undergo testing should receive genetic ...
As genetic and biomarker tests become more common, so do new therapies that target specific tumor types and may lead to ...
Genetic testing, via germline and somatic testing, is crucial in breast cancer to understand inherited risks and tumor ...
UCLA Health’s virtual genetic counseling tool has markedly increased the percentage of cancer patients undergoing recommended germline testing through a point-of-care model. Beth Karlan ...
Hosted on MSN18d
BRCA1 gene mutations may not be key to prostate cancer initiation, as previously thoughtAmong the 124 undergoing germline testing based on high risk, their average age was 56 (range 34–77). Again, germline BRCA2 variation predominated, with eight (8%) testing positive, but only one ...
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers ...
Of those tested, 50 (17%) harbored a germline pathogenic or likely pathogenic variant ... Factors associated with lower testing rates include socioeconomic conditions, the availability of on-site ...
Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022 Demand for germline hereditary cancer genetic testing has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback